BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16466165)

  • 1. [Clinical study on effect of xiongshao capsule on restenosis after percutaneous coronary intervention].
    Lu XY; Shi DZ; Xu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):13-7. PubMed ID: 16466165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effect of Xiongshao capsule on preventing restenosis post-PTCA or/and stenting].
    Xu H; Shi D; Chen K
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):494-7. PubMed ID: 11789203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ
    Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on correlation of blood-stasis syndrome and its accompanied syndromes with pathological changes showed in coronary angiography and restenosis after percutaneous coronary intervention].
    Xu H; Lu XY; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):8-13. PubMed ID: 17302055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention].
    Chu FY; Wang J; Sun XW; Xing YW; Yao KW; Wang SH; Li ZZ
    Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):729-35. PubMed ID: 19671410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
    Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
    Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
    Chen KJ; Shi DZ; Xu H; Lü SZ; Li TC; Ke YN; Zhang MZ; Lu XY; Sun RY; You SJ
    Chin Med J (Engl); 2006 Jan; 119(1):6-13. PubMed ID: 16454975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of xiongshao capsule in treating 112 patients with coronary heart disease angina pectoris of xin-blood stasis syndrome].
    Peng W; Shi DZ; Xue YT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):191-4. PubMed ID: 21425572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of shuxuetong in preventing restenosis after intracoronary stenting].
    Li AH; Gong KZ; Yan JF; Sun X; Feng Y; Zhang Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct; 24(10):879-81. PubMed ID: 15553817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome].
    Li J; Zhang MZ; Chen BJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan; 28(1):32-5. PubMed ID: 18418966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.
    Bestehorn HP; Neumann FJ; Büttner HJ; Betz P; Stürzenhofecker P; von Hodenberg E; Verdun A; Levai L; Monassier JP; Roskamm H
    J Am Coll Cardiol; 2004 Jun; 43(12):2160-5. PubMed ID: 15193674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on effect of concentrated xuefu zhuyu pill on restenosis of 43 cases coronary heart disease after intracoronary stenting].
    Yu B; Chen K; Mao J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Oct; 18(10):585-9. PubMed ID: 11477839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of liangxue shengji recipe on incidence of post-percutaneous coronary intervention restenosis and adverse cardiovascular events].
    Cui XY; Wu Y; Nong YB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan; 30(1):30-2. PubMed ID: 20353028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical observation on shu xin yi mai capsules for prevention of recurrent stricture after coronary artery introducing treatment.
    Duan X; Yang D; Zhang Y; Zhou C
    J Tradit Chin Med; 2003 Mar; 23(1):3-6. PubMed ID: 12747186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of pharmacological treatment versus percutaneous coronary angioplasty in patients with intermediate coronary artery lesions.
    Latacz P; Rostoff P; Gackowski A; El-Massri N; Konduracka E; Gajos G; Matysek J; Piwowarska W; Zmudka K
    Kardiol Pol; 2009 Aug; 67(8A):1004-12. PubMed ID: 19784905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of xiongshao capsule on vascular remodeling in porcine coronary balloon injury model].
    Xu H; Shi DZ; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Aug; 21(8):591-4. PubMed ID: 12575573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.